Mirabegron the first β3-adrenoceptor agonist for overactive bladder (OAB): a summary of the phase III studies

BJU Int. 2014 Jun;113(6):847-8. doi: 10.1111/bju.12773.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Acetanilides / administration & dosage*
  • Adrenergic beta-3 Receptor Agonists / administration & dosage*
  • Female
  • Humans
  • Male
  • Thiazoles / administration & dosage*
  • Urinary Bladder, Overactive / drug therapy*

Substances

  • Acetanilides
  • Adrenergic beta-3 Receptor Agonists
  • Thiazoles
  • mirabegron